CNS Pharmaceuticals

-$0.01 (-0.68%) Today
$0.00 (0.00%) As of 8:24 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.

CEO
John M. Climaco
Employees
5
Headquarters
Houston, Texas
Founded
2017

CNSP Key Statistics

Market Cap
39.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
112.61K
High Today
$1.51
Low Today
$1.43
Open Price
$1.50
Volume
121.77K
52 Week High
$4.46
52 Week Low
$1.39

CNSP Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure